Immune Modulation & Engineering Symposium
Immune Modulation & Engineering Symposium
批准号:
10609295
负责人:
Kara Lorraine Spiller
金额:
$1.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-20 至 2025-11-30
关键词:
Biomedical EngineeringCaringChildCollaborationsCommunicable DiseasesCommunitiesDisciplineDiseaseDisparity populationEngineeringEthnic OriginEventFamilyFutureGenderGoalsImmuneImmune System DiseasesImmune systemInfantInjuryLocationMalignant NeoplasmsMissionMolecularPatient RecruitmentsPhiladelphiaPublishingRegenerative MedicineResearchResearch PersonnelResourcesScienceScientistSeriesSurveysTissue EngineeringUnderrepresented PopulationsUniversitiescancer cellcareerclinical translationdisabilitydisadvantaged backgroundimmunoengineeringimmunoregulationindustry partnerinnovationinnovative technologiesnanomedicinenew technologynext generationsuccesssymposiumsynthetic biologytranslational immunologytumor immunology
中文摘要
项目摘要
第四届免疫调节与工程学术年会的使命
德雷克塞尔大学将于2022年12月7日至9日汇聚生物医学工程和基础与基础研究人员
翻译免疫学推动了快速崛起的免疫工程领域的发展。演讲者和
与会者代表该领域的领导者,拥有跨学科协作的专业知识,以产生创新
治疗癌症、传染病、免疫紊乱和重大伤害的解决方案
免疫系统。本次研讨会的主要目的是提供一个分享尖端技术的论坛。
免疫调节方面的想法,以刺激跨学科合作,引入下一代
科学家向这一新领域进军,并确定挑战和机遇,以推进新的和创新的
技术。
费城是举办这项活动的最佳地点,因为它是公认的免疫调节和
工程学,拥有一个由学术、创业和行业合作伙伴组成的蓬勃发展的社区。多种多样
在费城的研究是整个世界存在的一个缩影,免疫领域
工程和调制当然是多种多样的--涵盖了从分子工程到分子工程的各个主题
到临床翻译。为了涵盖这一广泛的研究范围,我们建议开发一系列四个
集中在研讨会中,每次集中包括两次主旨演讲
演讲者阵容多种多样。这些浓度包括:癌症免疫学和细胞递送,免疫调节
损伤和疾病、纳米医学和合成生物学、再生医学和免疫组织
工程学。
我们致力于每年举办一次高质量的研讨会,同时展示
我们领域的多样性。为支持这一目标,今年将举办首届《多元化视角》
免疫工程开幕招待会,将展示和庆祝不同团队在该领域的价值。
组委会在性别、种族、职业阶段和
科学纪律。同样,我们选择了免疫领域现任或未来领导者的发言者
工程师,他们的构成和背景也是多种多样的。在整个规划阶段,我们将
继续寻求我们的同事的意见,他们代表弱势背景的人,
残疾人和其他在科学界代表性不足的群体,并尽一切努力从
不同的背景。最后,我们将帮助与会者确定附近地区的儿童和家庭护理资源
在研讨会上,我们将明确表示,欢迎婴儿参加研讨会。
英文摘要
Project Summary
The mission of the 4th Annual Immune Modulation and Engineering symposium, which will be held at
Drexel University on Dec. 7-9, 2022 is to bring together researchers in biomedical engineering and basic and
translational immunology to advance the rapidly emerging field of immune engineering. The speakers and
attendees represent leaders in this field, with expertise in collaborating across disciplines to generate innovative
solutions to treat cancer, infectious disease, immunological disorders and major injuries by modulating the
immune system. The major objectives of this symposium are to provide a forum for the sharing of cutting edge
ideas in immunomodulation, to stimulate cross-disciplinary collaborations, to introduce the next generation of
scientists to this new field, and to identify challenges and opportunities to advance new and innovative
technologies.
Philadelphia is a prime location to host this event, as it is a recognized hub for immune modulation and
engineering, with a thriving community comprising academic, entrepreneurial, and industry partners. The variety
of research within Philadelphia is a microcosm of that which exists throughout the world, and the field of immune
engineering and modulation is certainly diverse – encompassing topics which span from molecular engineering
to clinical translation. In order to cover this broad spectrum of research, we propose to develop a series of four
concentrations within the symposium with each concentration including two sessions of keynote talks from a
diverse lineup of speakers. These concentrations include: cancer immunology & cell delivery, immunoregulation
of injury and disease, nanomedicine and synthetic biology, and regenerative medicine and immune tissue
engineering.
We are committed to hosting an annual symposium that is of the highest quality while also showcasing
the diversity in our fields. In support of this goal, this year will feature the inaugural Diverse Perspectives in
Immune Engineering opening reception, which will showcase and celebrate the value of diverse team in this field.
The organizing committee represents diverse representation in terms of gender, ethnicity, career stage, and
scientific discipline. Similarly, we have selected speakers who are current or future leaders in the field of immune
engineering who are also diverse in their make-up and background. Throughout the planning stages we will
continue to seek input from our colleagues who represent persons from disadvantaged backgrounds, those with
disabilities, and other underrepresented groups in science, and make every attempt to recruit participants from
diverse backgrounds. Finally, we will help attendees identify resources for child and family care in the vicinity of
the symposium, and we will make it clear that infants are welcome at the symposium.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Particle-Assisted Control over Macrophage-Neutrophil interactions (Pac-Man)
-
批准号:10725989
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2023
-
负责人:Kara Lorraine Spiller
-
依托单位:
Inflammation-related gene biomarkers in human diabetic foot ulcer healing
-
批准号:10658986
-
项目类别:
-
资助金额:$46.45万
-
财政年份:2022
-
负责人:Kara Lorraine Spiller
-
依托单位:
Immune Modulation & Engineering Symposium
-
批准号:10392105
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2020
-
负责人:Kara Lorraine Spiller
-
依托单位:
Understanding and Controlling Macrophage Behavior in Angiogenesis
-
批准号:9340738
-
项目类别:
-
资助金额:$5.49万
-
财政年份:2017
-
负责人:Kara Lorraine Spiller
-
依托单位:
Understanding and Controlling Macrophage Behavior in Angiogenesis
-
批准号:9002582
-
项目类别:
-
资助金额:$39.13万
-
财政年份:2016
-
负责人:Kara Lorraine Spiller
-
依托单位:
Understanding and Controlling Macrophage Behavior in Angiogenesis
-
批准号:10889772
-
项目类别:
-
资助金额:$7.74万
-
财政年份:2016
-
负责人:Kara Lorraine Spiller
-
依托单位:
Understanding and Controlling Macrophage Behavior in Angiogenesis
-
批准号:10629777
-
项目类别:
-
资助金额:$7.74万
-
财政年份:2016
-
负责人:Kara Lorraine Spiller
-
依托单位:
Understanding and Controlling Macrophage Behavior in Angiogenesis
-
批准号:9198940
-
项目类别:
-
资助金额:$39.13万
-
财政年份:2016
-
负责人:Kara Lorraine Spiller
-
依托单位:
Understanding and Controlling Macrophage Behavior in Angiogenesis
-
批准号:10296177
-
项目类别:
-
资助金额:$59.53万
-
财政年份:2016
-
负责人:Kara Lorraine Spiller
-
依托单位:
Understanding and Controlling Macrophage Behavior in Angiogenesis
-
批准号:10682565
-
项目类别:
-
资助金额:$58.89万
-
财政年份:2016
-
负责人:Kara Lorraine Spiller
-
依托单位:
Understanding and Controlling Macrophage Behavior in Angiogenesis
-
批准号:10471405
-
项目类别:
-
资助金额:$59.53万
-
财政年份:2016
-
负责人:Kara Lorraine Spiller
-
依托单位:
海外基金